Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Myeloid 1Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Colorectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 2Thyroid Neoplasms 1Ras-mutated Metastatic Colorectal Cancer 1Ovarian Neoplasms 1Lung Neoplasms 1Histiocytosis 1Gastrointestinal Neoplasms 1Gastroesophageal Adenocarcinoma 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Neuroendocrine 1Carcinoma, Basal Cell 1CRC 1Brain Neoplasms 1Advanced Gastric or EGJ Cancer 1

Interventions

Radiosurgery 31Magnetic Resonance Spectroscopy 16Temozolomide 12pembrolizumab 11Nivolumab 10Specimen Handling 8Ipilimumab 8Bevacizumab 8Radiotherapy 7Mental Status and Dementia Tests 7Memantine 7abemaciclib 5Blood Specimen Collection 5Biopsy 4trastuzumab deruxtecan 3entrectinib 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Sodium Chloride 3Saline Solution 3Receptors, Interleukin-8B 3Proton Therapy 3Dexamethasone 3Cyclophosphamide 3trametinib 2pertuzumab 2osimertinib 2fluciclovine F-18 2contrast agent BR1 2atezolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × IFL protocol × 90 days × Clear all
NCT05786924 2026-04-21

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Servier

Phase 1/2 Recruiting
554 enrolled
CNSGastrointestinalHead & NeckMyeloidThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Histiocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡